Results 31 to 40 of about 337,818 (177)

Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies. [PDF]

open access: yesBr J Haematol
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Joshi G   +3 more
europepmc   +2 more sources

Erythrodontia in congenital erythropoietic porphyria. [PDF]

open access: yesJ Oral Maxillofac Pathol, 2011
Congenital erythropoietic porphyria (CEP) is one of the rarest of porphyrias occurring worldwide. CEP is a very rare genetic autosomal recessive disease, with mutation in the gene that codifies uroporphyrinogen-III synthase, leading to porphyrin accumulation in many tissues, with marked skin photosensitivity, hemolytic anemia with splenomegaly and a ...
Bhavasar R, Santoshkumar G, Prakash BR.
europepmc   +4 more sources

Neonatal hemolytic anemia does not always indicate thalassemia: a case report

open access: yesBMC Research Notes, 2017
Background Congenital erythropoietic porphyria is a rare autosomal recessive disorder that affects heme-porphyrin synthesis. This disorder is due to the genetic defect of uroporphyrinogen III cosynthase.
Arwa A. Al-Harazi   +2 more
doaj   +1 more source

Gunther’s Disease: Esthetic Management of Erythrodontia; 1-year Follow-up [PDF]

open access: yesInternational Journal of Prosthodontics and Restorative Dentistry, 2023
Intrinsic tooth stains are more permanent in nature than extrinsic stains and can be divided into two types systemic and local. Erythrodontia is reddish-brown or reddish-black discoloration of teeth caused due to congenital erythropoietic porphyria (CEP)
Pranjal Sharma   +2 more
doaj   +1 more source

Congenital erythropoietic porphyria: Recent advances. [PDF]

open access: yesMol Genet Metab, 2019
Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder characterized by photosensitivity and by hematologic abnormalities in affected individuals. CEP is caused by mutations in the uroporphyrinogen synthase (UROS) gene. In three reported cases, CEP has been associated with a specific X-linked GATA1 mutation.
Erwin AL, Desnick RJ.
europepmc   +4 more sources

Transcription Factors GATA1/2 in Hematological Disorders. [PDF]

open access: yesEJHaem
ABSTRACT Background GATA1 and GATA2 are zinc‐finger transcription factors essential for normal hematopoiesis. As genetic testing becomes more widely integrated into clinical practice, GATA1/2‐related disorders are increasingly recognized, making it important for clinicians to understand their diagnosis and management.
Karr M, Palmisiano N, Chen X.
europepmc   +2 more sources

Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias

open access: yesMetabolites, 2014
Heme, like chlorophyll, is a primordial molecule and is one of the fundamental pigments of life. Disorders of normal heme synthesis may cause human diseases, including certain anemias (X-linked sideroblastic anemias) and porphyrias.
Siddesh Besur   +3 more
doaj   +1 more source

Advanced drug delivery systems targeting to improve therapeutic outcomes in porphyria

open access: yes, 2023
Porphyrias are known as disorders of the heme biosynthesis pathway. There are about eight metabolic disorders that make up the porphyrias. These eight metabolic disorders are porphyria cutanea tarda, acute intermittent porphyria, ALA-dehydratase ...
Dua, K   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy